MRI Report Says “Atrophy” or “White Matter Disease”? What I Look For as a Dementia Doctor

If your brain MRI report says “atrophy” or “white matter disease / chronic ischemic changes,” it can sound scary. In this episode of The Dementia Doctor, behavioral neurologist Dr Khushboo Verma explains—using simple language—what dementia specialists actually look for on MRI, and how those findings can support (but not always confirm) different dementia diagnoses. 🧠 What “atrophy” really means Atrophy = brain shrinkage. Some degree of brain volume loss occurs with normal aging. Dementia specialists focus on patterns of atrophy (where it is most prominent), because the location can be more informative than the fact that shrinkage exists. 🧠 Common patterns doctors consider This video walks through how MRI patterns can suggest different causes—always in combination with age, symptoms, and exam: Alzheimer’s disease (AD): Often more prominent atrophy in medial temporal regions (memory-related structures) and parietal association areas. MRI can support a probable clinical diagnosis, but AD is best confirmed by biomarkers (amyloid and tau testing via CSF, PET, or blood-based tests where available). Frontotemporal dementia (FTD): More prominent atrophy in frontal and/or anterior temporal lobes, often presenting at a younger age with behavior, executive, or language syndromes. MRI pattern helps, but diagnosis still relies heavily on the clinical picture and excluding other causes. Lewy body dementia (LBD): MRI may show less specific or more diffuse atrophy patterns; diagnosis depends strongly on clinical features such as fluctuations, visual hallucinations, REM sleep behavior disorder, and Parkinsonism. 🧠 What “white matter disease / chronic ischemic changes” means These terms usually refer to small vessel changes in the brain’s wiring (“white matter”), often seen as bright areas on MRI sequences such as FLAIR. They are commonly associated with vascular risk factors such as hypertension, diabetes, high cholesterol, smoking, and obesity. Mild changes are very common with aging and may not explain symptoms by themselves. More extensive/confluent changes can contribute to vascular cognitive impairment (often affecting processing speed, attention, and executive function). ✅ One key takeaway MRI is extremely helpful to: rule out structural causes (tumor, large stroke, bleeding), and add evidence toward a likely dementia type, especially vascular contributions. But for many neurodegenerative dementias, MRI is supportive, not definitive. When needed, the next step is biomarker testing (especially for Alzheimer’s). 🩺 Medical Disclaimer This video is for education only and is not personal medical advice. Please review your MRI results with your neurologist or dementia specialist, and ask them to show you the images and explain how the findings fit your symptoms. #Dementia #Alzheimers #BrainMRI #MRIReport #Atrophy #WhiteMatterDisease #VascularCognitiveImpairment #FTD #LewyBodyDementia #TheDementiaDoctor